Hematologic Malignancies
News
Complex link between gut microbiome and immunotherapy response in advanced melanoma
Previous studies have identified the gut microbiome as “a potential biomarker of response as well as a therapeutic target” in melanoma and other...
News
FDA approves new CAR T-cell treatment for multiple myeloma
Study results show that this treatment for refractory/relapsed multiple myeloma can provide deep, durable responses and long treatment-free...
Conference Coverage
AGILE: ‘Exciting’ survival results for IDH1-mutated AML
Results show survival that is three times longer for a combination of ivosidenib plus azacitidine versus azacitidine alone in a distinct...
Conference Coverage
Isatuximab added to RVd boosts response in new myeloma
A drug approved in 2020 for treatment of advanced multiple myeloma has been shown to benefit patients newly diagnosed with the disease.
Conference Coverage
Talk early to patients with high-risk AML about end-of-life decisions
With nearly 40% of AML patients unable to take part in their own final code discussions, families struggle to guess what their loved ones would...
Conference Coverage
Beta-thalassemia gene therapy achieves lasting transfusion independence
“Seeing the restoration of iron metabolism, it really takes us a step closer to really thinking the term ‘cure’ might truly apply.”
News
FDA approves time-saving combo for r/r multiple myeloma
“The approval will help clinicians address unmet patient needs by reducing the administration time from hours to just minutes and reducing the...
News
Decades spent searching for genes linked to rare blood cancer
Tantalizing clues about WM and related B-cell cancers have emerged.
News
Vaccines weaker than expected in multiple myeloma patients
New study sheds light on how vulnerable multiple myeloma patients are to COVID-19.
Case Reports
Orbital Varix Masquerading as an Intraorbital Lymphoma
Clinical context was paramount to the diagnosis and management of a patient with periorbital pain and history of systemic lymphoma.